News of the WeekImmunology

Painful Failure of Promising Genital Herpes Vaccine

Science  15 Oct 2010:
Vol. 330, Issue 6002, pp. 304
DOI: 10.1126/science.330.6002.304

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

A vaccine designed to ward off genital herpes has failed in a large clinical trial, abruptly ending the product's seemingly promising future. After 8 years of study in more than 8000 women in the United States and Canada, there was not even a hint of a positive result against the sexually transmitted disease caused by herpes simplex virus-2.

Related Content